• Profile
Close

Sclerotherapy for reticular veins in the lower limbs: A triple-blind randomized clinical trial

JAMA Dermatology Nov 05, 2017

Bertanha M, et al. - A comparative assessment was carried out of the efficacy and safety of 2 sclerosants used to treat reticular veins: 0.2% polidocanol diluted in 70% hypertonic glucose (HG) (group 1) vs 75% HG alone (group 2). The findings revealed the superiority of sclerotherapy with 0.2% polidocanol diluted in 70% HG than the 75% HG alone in sclerosing reticular veins. The yielded data did not disclose any statistical variation for complications. Both groups reported the occurrence of pigmentation, with no statistical change between them. Neither group presented with any serious adverse events.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay